MPC1L

Across TCGA pan-cancer cohorts, MPC1L Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MPC1L data layer compared with 14 for mass-spec protein.

The strongest signal is observed in small cell lung cancer (SCLC), where higher MPC1L Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MPC1L expression acts as an unfavorable survival marker.

SCLC are the cancer types where MPC1L Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Median	II,III,IV	0.192	0.699	.002	15	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MPC1L–SCLC (OS)

Open the SCLC breakdown →